Latest News
|
More Articles...
- BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III
- Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation
- CardioFocus Announces Impressive Results from Pivotal Confirmatory Study with The Breakthrough HeartLight® X3 System
- Late-Breaking Trial Data Highlight Continued Clinical Success of Boston Scientific EMBLEM™ S-ICD System
- CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device
- New findings provide definitive management guidelines for patients on direct oral anticoagulants with atrial fibrillation undergoing elective procedures or surgeries
- Duration of External ECG Monitoring is Critical to Detecting Atrial Fibrillation
- ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA®▼ (edoxaban) in Elderly NVAF Patients
- FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System
- FDA approves new device to improve symptoms in patients with advanced heart failure
|
|
